Patients with head and neck cancer who attended a survivorship clinic before completing RT were more likely to complete treatment on schedule and had better 3-year DFS than those who did not attend.

In the head-to-head TRANSCEND-T2D-2 trial, participants with type 2 diabetes (T2D) lost more than twice as much weight with retatrutide as with Ozempic (semaglutide) and had a greater reduction in A1c ...

Cancer survivors who adhered to the Dietary Approaches to Stop Hypertension (DASH) diet and other healthy eating patterns showed as much as a one-third lower risk of developing cardiovascular disease ...

Nearly 3 in 4 former National Football League (NFL) players who died between 2008 and 2023 likely had chronic traumatic encephalopathy (CTE), a new study suggested. The population-based ...

Patients with rheumatoid arthritis (RA) incidence in 2010-2019 achieved remission within the first year at higher rates than those diagnosed in 1990-1999. Median time to remission shortened from 6.4 ...

Short-acting bronchodilators remain the rescue inhalers for asthma and chronic obstructive pulmonary disease (COPD), yet the Global Initiative for Asthma (GINA) 2026 report states that asthma should ...

A patient started on a once-daily inhaled corticosteroid/long-acting beta-agonist (ICS/LABA) inhaler for COPD and a patient started on that same class of inhaler ...

In COPD, two single-inhaler triple therapies have trial-based mortality findings that neither current US label includes as an efficacy claim. Trelegy Ellipta ...

In patients who presented to the emergency department (ED) with a possible myocardial infarction (MI), a point-of-care high-sensitivity cardiac troponin I (hs-cTnI) test was associated with shorter ...

For most patients starting maintenance therapy for COPD in 2026, a long-acting beta-agonist (LABA) prescribed alone is no longer the default first prescription. GOLD 2026 sorts patients not yet on ...

WASHINGTON — Children whose pediatricians recommended initiating the human papillomavirus (HPV) vaccination series at ages 9-10 had over twice the odds of starting and completing the series by age 13 ...

Research presented at the American Academy of Ophthalmology (AAO) 2026 Annual Meeting in New Orleans examined how beauty products can harm the eyes, offered longer-term data on a system to improve ...